Based on this, we hypothesized that the MEK/ERK1/2 pathway (involved in cell growth and proliferation) and the p38 MAPK and JNK pathways (stress-induced pathways) have roles in the resistance of CLL cells to venetoclax. This evidence concerns the gene MAP2K7 and B-cell chronic lymphocytic leukemia.